GJO & Partners
← All funds

Eisai

Public data, unclaimed profile

Investisseur référencé à partir d'opérations publiées. Secteurs, pays, instruments et tickets affichés d'après ses opérations ; le fonds peut revendiquer sa fiche pour préciser sa thèse.

At a glance

Based on observed investment behaviour: 1 recorded deal

Investor type
Private equity or venture capital fund (inferred, not verified)
Capital type
Private equity (inferred from profile)
Observed ticket
Data unavailable
Countries
South Africa (1)
Activities
Health platforms and software (1)
Instruments
Data unavailable
Stages
Data unavailable
Recent activity
0 deal in 12 months, latest Mar 2024

Stated thesis versus observed behaviour

Fewer than three recorded deals: insufficient evidence to compare thesis and behaviour.

Does this fund fit your project?

Describe your need: the target list shows, for each source of capital, why it fits and which deals prove it.

Find my matches

Investment thesis

Criteria inferred from recorded deals: the fund has not stated its thesis yet.

Investment ticket
n/a
Instruments
—
Preferred sectors
Digital health*
Target geographies
South Africa*

* added from its deals

Reference deals

Recent public deals: they say better than a thesis what the fund actually signs.

RecoMed

March 2024 · South Africa
Undisclosed amountDigital healthLead

Activity : Health platforms and software

RecoMed , a South African digital healthcare marketplace company, has raised new funding from the Japanese pharmaceutical firm Eisai .

Source : weetracker.com

In short

Eisai invests across the following sectors: Digital health, in the following areas: South Africa. Check in 30 seconds whether your company fits these criteria.